Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine Plus Carboplatin in Patients With Pretreated Metastatic Breast Cancer
NCT00450762Phase 2Completed
- Sponsor
- Ludwig Maximilian University of Munich
- Start
- Mar 2004
- Modality
- DNA Intercalators/Alkylators
01
Overview
A Phase 2 trial of gemcitabine, carboplatin in breast cancer, sponsored by Ludwig Maximilian University of Munich. Started Mar 2004; status: completed.
02
Drugs
gemcitabinecarboplatin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00450762.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00450762.